Ticker: FHTX

Foghorn Therapeutics Inc. (NASDAQ: FHTX) Foghorn Therapeutics, a clinical-stage biopharmaceutical company, focuses on developing a new class of medicines targeting the chromatin regulatory system. They are at the forefront of creating novel oncology drugs, leveraging their proprietary Gene Traffi...